
About Us
Our scientific focus is small molecule therapeutics that amend disease pathways by direct cellular absorption to improve biological function. In large part, our research is based upon the use and application of hydroxytyrosol and oleuropein molecules that are complexed with sulfur containing amino acids.
The company currently has nine patents issued and nine pending. The patents concern nutrition, wound care, endothelial cell survival and cancer with an emphasis on leukemia.